Relay Therapeutics Inc. Common Stock vs Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.82B), while Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) trades at $24.85 (market cap $156.97B). The key difference: Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) is far larger — about 41.1× Relay Therapeutics Inc. Common Stock's market cap, and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) pays a 2.34% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Sumitomo Mitsui Financial Group Inc Unsponsored American Depositary Shares (Japan) for 0 Days on average.
| RLAY | SMFG | |
|---|---|---|
Market Cap | $3.82B | $156.97B |
Volume | 4,332,079 | 1,237,125 |
Sector | Health | Financials |
52-Week High | $20.75 | $27.56 |
52-Week Low | $6.03 | $15.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.93B | $12.48T |
Dividend Yield | — | 2.34% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Sumitomo Mitsui Financial Group is a Japanese financial services company with banking, securities, leasing, and asset management businesses. It serves retail, corporate, and institutional clients.
Read more on SMFG →